Jefferies Reiterates Buy Rating on The Best Large Cap Biotech...Vertex (VRTX)
Tweet Send to a Friend
Jefferies analyst Michael Yee reiterated a Buy rating and $275.00 price target on Vertex (NASDAQ: VRTX) after the company guided ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
